Solvent-free Temperature-Facilitated Direct Extrusion 3D Printing for Pharmaceuticals
Autor: | Rober Habashy, Beatriz C. Pereira, Tim Gough, Mohamed Albed Alhnan, Matthew Peak, Magdalena Kuźmińska, Mohammad Isreb, Abdullah Isreb |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2021 |
Předmět: |
RM
Materials science Pharmaceutical Science 3D printing 02 engineering and technology Methacrylate 030226 pharmacology & pharmacy Dosage form 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine Triethyl citrate F151 business.industry Temperature 021001 nanoscience & nanotechnology Solvent Drug Liberation chemistry Chemical engineering Printing Three-Dimensional Solvents Extrusion Extensional viscosity Polymer blend 0210 nano-technology business Tablets |
ISSN: | 1873-3476 0378-5173 |
Popis: | In an era moving towards digital health, 3D printing has successfully proven its applicability in providing personalised medicine through a technology-based approach. Among the different 3D printing techniques, direct extrusion 3D printing has been demonstrated as a promising approach for on demand manufacturing of solid dosage forms. However, it usually requires the use of elevated temperatures and/or the incorporation of an evaporable solvent (usually water). This can implicate the addition of a drying step, which may compromise the integrity of moisture- or temperature-sensitive drugs, and open the door for additional quality control challenges. Here, we demonstrate a new approach that simplifies direct extrusion 3D printing process with the elimination of the post-printing drying step, by merely adding a fatty glyceride, glyceryl monostearate (GMS), to a model drug (theophylline) and permeable water insoluble methacrylate polymers (Eudragit RL and RS). Indeed, rheological studies indicated that the addition of a combination of a plasticiser, (triethyl citrate), and GMS to theophylline: methacrylate polymer blends significantly reduced the extensional viscosity (to < 2.5 kPa.Sec) at 90 C. Interestingly, GMS demonstrated a dual temperature-dependant behaviour by acting both as a plasticiser and a lubricant at printing temperature (90-110 °C), while aiding solidification at room temperature. X-ray powder diffraction indicated incomplete miscibility of GMS within the polymeric matrix at room temperature with the presence of a subtle diffraction peak, at 2(Θ)= 20. The 3D printed tablets showed acceptable compendial weight and content uniformity as well as mechanical resistance. In vitro theophylline release from 3D printed tablets was dependant on Eudragit RL:RS ratio. All in all, this work contributes to the efforts of developing a simplified, facile and low-cost 3D printing for small batch manufacturing of bespoke tablets that circumvents the use of high temperature and post-manufacturing drying step. [Abstract copyright: Copyright © 2021. Published by Elsevier B.V.] |
Databáze: | OpenAIRE |
Externí odkaz: |